Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-Current Debt (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Non-Current Debt for 16 consecutive years, with $17.4 million as the latest value for Q3 2025.

  • Quarterly Non-Current Debt fell 9.06% to $17.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Sep 2025, down 9.06% year-over-year, with the annual reading at $22.0 million for FY2024, 28.37% up from the prior year.
  • Non-Current Debt for Q3 2025 was $17.4 million at Xtant Medical Holdings, down from $22.3 million in the prior quarter.
  • The five-year high for Non-Current Debt was $22.3 million in Q2 2025, with the low at $9.7 million in Q4 2022.
  • Average Non-Current Debt over 5 years is $15.6 million, with a median of $15.4 million recorded in 2023.
  • The sharpest move saw Non-Current Debt tumbled 85.33% in 2021, then soared 77.22% in 2023.
  • Over 5 years, Non-Current Debt stood at $11.8 million in 2021, then dropped by 17.82% to $9.7 million in 2022, then surged by 77.22% to $17.2 million in 2023, then grew by 28.37% to $22.0 million in 2024, then fell by 21.03% to $17.4 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $17.4 million, $22.3 million, and $22.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.